Literature DB >> 24657794

Infectious morbidity is higher after second-stage compared with first-stage cesareans.

Methodius G Tuuli1, Lucy Liu2, Ryan E Longman2, Anthony O Odibo2, George A Macones2, Alison G Cahill2.   

Abstract

OBJECTIVE: The objective of the study was to compare maternal and neonatal infectious morbidity following cesareans performed in the second and first stages of labor. STUDY
DESIGN: We conducted a retropective cohort study of all consecutive, singleton, term, cesarean deliveries in laboring women in a single institution from 2005 to 2012. Second-stage cesareans were defined as those performed at complete cervical dilation (10 cm), and first-stage cesareans were those performed before 10 cm cervical dilation. The primary outcome was endometritis. Rates of infectious morbidity were compared in the 2 groups. Multivariable logistic regression was used to calculate adjusted risk estimates.
RESULTS: Of 2505 cesareans meeting inclusion criteria, 400 (16.0%) were performed in the second stage, whereas 2105 (84.0%) were performed in the first stage of labor. The risk of endometritis was nearly 3-fold higher in second- compared with first-stage cesareans (4.25% vs 1.52%; crude odds ratio, 2.88; 95% confidence interval, 1.58-5.23). The risk remained significantly higher after controlling for confounders (adjusted odds ratio, 2.78; 95% confidence interval, 1.51-5.09).
CONCLUSION: Second-stage cesarean is associated with an increased risk of endometritis compared with first-stage cesarean. Further studies will determine whether different infection preventive strategies are needed at second-stage cesareans to reduce endometritis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cesarean; first stage; infections; labor; second stage

Mesh:

Year:  2014        PMID: 24657794      PMCID: PMC4410720          DOI: 10.1016/j.ajog.2014.03.040

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis.

Authors:  M G Martens; S Faro; M Maccato; G Riddle; H A Hammill
Journal:  Am J Obstet Gynecol       Date:  1991-05       Impact factor: 8.661

2.  Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis.

Authors:  Alan T N Tita; John C Hauth; Anne Grimes; John Owen; Alan M Stamm; William W Andrews
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

3.  Timing of perioperative antibiotics for cesarean delivery: a metaanalysis.

Authors:  Maged M Costantine; Mahbubur Rahman; Labib Ghulmiyah; Benjamin D Byers; Monica Longo; Tony Wen; Gary D V Hankins; George R Saade
Journal:  Am J Obstet Gynecol       Date:  2008-09       Impact factor: 8.661

4.  The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed.

Authors:  R Plowman; N Graves; M A Griffin; J A Roberts; A V Swan; B Cookson; L Taylor
Journal:  J Hosp Infect       Date:  2001-03       Impact factor: 3.926

5.  The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Authors:  J D Iams; R L Goldenberg; B M Mercer; A Moawad; E Thom; P J Meis; D McNellis; S N Caritis; M Miodovnik; M K Menard; G R Thurnau; S E Bottoms; J M Roberts
Journal:  Am J Obstet Gynecol       Date:  1998-05       Impact factor: 8.661

Review 6.  Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections.

Authors:  David M Haas; Sarah Morgan; Karenrose Contreras
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

Review 7.  Antibiotic prophylaxis for cesarean section.

Authors:  F Smaill; G J Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2002

8.  The risk of acute neonatal morbidities in the delivery room after primary cesarean at term: influence of labor and stage.

Authors:  Kim C Winovitch; Deborah A Wing; David C Lagrew; Judith H Chung
Journal:  Am J Perinatol       Date:  2009-05-18       Impact factor: 1.862

9.  Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study.

Authors:  C Wloch; J Wilson; T Lamagni; P Harrington; A Charlett; E Sheridan
Journal:  BJOG       Date:  2012-08-01       Impact factor: 6.531

10.  Comparison of nulliparas undergoing cesarean section in first and second stages of labour: a prospective study in a tertiary teaching hospital.

Authors:  Ayhan Sucak; Sevki Celen; Eren Akbaba; Sunullah Soysal; Ozlem Moraloglu; Nuri Danışman
Journal:  Obstet Gynecol Int       Date:  2011-09-20
View more
  5 in total

1.  Obesity, Second Stage Duration, and Labor Outcomes in Nulliparous Women.

Authors:  Antonina I Frolova; Nandini Raghuraman; Molly J Stout; Methodius G Tuuli; George A Macones; Alison G Cahill
Journal:  Am J Perinatol       Date:  2019-09-28       Impact factor: 1.862

2.  Surgical Site Infection following Cesarean Delivery: Patient, Provider, and Procedure-Specific Risk Factors.

Authors:  Raj Shree; Seo Young Park; Richard H Beigi; Shannon L Dunn; Elizabeth E Krans
Journal:  Am J Perinatol       Date:  2015-09-07       Impact factor: 1.862

3.  Evaluating the impact of a standardized induction protocol to reduce adverse perinatal outcomes: a prospective cohort study.

Authors:  Lisa D Levine; Katheryne L Downes; Rebecca F Hamm; Sindhu K Srinivas
Journal:  J Matern Fetal Neonatal Med       Date:  2019-10-24

Review 4.  Surgical site infections after cesarean delivery: epidemiology, prevention and treatment.

Authors:  Tetsuya Kawakita; Helain J Landy
Journal:  Matern Health Neonatol Perinatol       Date:  2017-07-05

5.  Evaluation of Epidural Analgesia Use During Labor and Infection in Full-term Neonates Delivered Vaginally.

Authors:  Lijie Jia; Huimin Cao; Yuna Guo; Ying Shen; Xiaoyu Zhang; Zhou Feng; Jiangruixuan Liu; Zhongcong Xie; Zifeng Xu
Journal:  JAMA Netw Open       Date:  2021-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.